Expectations trend
FY2028 · fiscal year ending 2028-09-28 · fmp
Tetra Tech (TTEK)
NASDAQIndustrialsEngineering & ConstructionSnapshot 2026-11-05
$40.56-0.93%
Close 2026-11-05 · 1-day change
NASDAQIndustrialsEngineering & ConstructionSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
1.88 → 1.90 EPS · FY ending Sep 28, 2028 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for TTEK yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Dividend per share grows to at least $0.07 per quarter | The company grows its dividend steadily, showing strong cash flow. | Intact | dividend per share falls below $0.07 per quarter | Dividend per share: $0.07 per share FY2026-Q3; GAAP. Published target: >= $0.07 per share per quarter. Target period is not explicitly aligned with this observation. Jul 31, 20260.072 USD/share · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-09-28 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 11, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is an execution-led growth business, with recent revenue and earnings guidance increases supporting its multi-year view. The thesis is intact, but momentum has weakened and confidence has moved from high to medium.
Valuation is tagged as stretched, even though the model shows TTEK as cheap versus peers. The expectations gap is 0.17, but the evidence does not specify what the market assumes in detail; execution quality is the main noted source of fragility.
Near-term results have been supported by reported revenue, backlog growth, and higher full-year revenue and adjusted EPS guidance. Management has also kept dividend growth on track, while the recent earnings beat is a positive signal. Risks remain elevated, and sector conditions are a headwind; recent momentum has fallen sharply.
A key near-term test is whether management raises guidance again after the prior guidance reduction noted in the evidence. Over the multi-year view, continued backlog and earnings execution matter, alongside whether sector bellwethers keep beating and raising guidance or begin missing and lowering it.
The 1-3 year thesis remains intact, but weaker momentum, elevated risk, and a headwind from the sector make continued execution important. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 2 of 2 supplied quarters. Management reported: “Quarterly Dividend and Share Repurchase Program On July 27, 2026, Tetra Tech’s Board of Directors approved a quarterly dividend in the amount of $0.072 per share, an 11% increase year-over-year, payable on August 27, 2026, to stockholders of record as of August 13, 2026.” “This is the 45 th consecutive double-digit increase in the Company’s quarterly dividend.”
Full year EPS reaches at least $1.50 in fiscal 2026 | A primary condition in Tetra Tech's published investment case. The stated target is >= $1.50 per share. | Intact | full year EPS falls below $1.50 in FY26 | Diluted EPS: $0.42 per share FY2026-Q3; GAAP. Published target: >= $1.50 per share. Annual target cannot be compared with a quarterly or TTM observation. Jul 31, 20260.42 USD/share · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Full year revenue reaches at least $4.25 billion in fiscal 2026 | A primary condition in Tetra Tech's published investment case. The stated target is >= $4.25 billion. | Intact | full year revenue falls below $4.25 billion in FY26 | Revenue: $1.309B FY2026-Q3; GAAP. Published target: >= $4.25 billion. Annual target cannot be compared with a quarterly or TTM observation. Jul 31, 20261,308,555,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.88 → $1.90 · observed estimates
$4.62B → $4.70B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-09-29 | $1.88 | $4,624,700,000 | 1 / 1 |
| 2026-09-30 | $1.88 | $4,624,700,000 | 1 / 1 |
| 2026-10-01 | $1.88 | $4,624,700,000 | 1 / 1 |
| 2026-10-02 | $1.88 | $4,624,700,000 | 1 / 1 |
| 2026-10-03 | $1.88 | $4,624,700,000 | 1 / 1 |
| 2026-10-04 | $1.88 | $4,624,700,000 | 1 / 1 |
| 2026-10-05 | $1.88 | $4,624,700,000 | 1 / 1 |
| 2026-10-06 | $1.88 | $4,624,700,000 | 1 / 1 |
| 2026-10-07 | $1.88 | $4,624,700,000 | 1 / 1 |
| 2026-10-08 | $1.88 | $4,624,700,000 | 1 / 1 |
| 2026-10-09 | $1.88 | $4,624,700,000 | 1 / 1 |
| 2026-10-10 | $1.88 | $4,624,700,000 | 1 / 1 |
| 2026-10-11 | $1.88 | $4,624,700,000 | 1 / 1 |
| 2026-10-12 | $1.88 | $4,624,700,000 | 1 / 1 |
| 2026-10-13 | $1.88 | $4,624,700,000 | 1 / 1 |
| 2026-10-14 | $1.88 | $4,624,700,000 | 1 / 1 |
| 2026-10-15 | $1.90 | $4,698,450,000 | 1 / 1 |
| 2026-10-16 | $1.90 | $4,698,450,000 | 1 / 2 |
| 2026-10-17 | $1.90 | $4,698,450,000 | 1 / 2 |
| 2026-10-18 | $1.90 | $4,698,450,000 | 1 / 2 |
| 2026-10-19 | $1.90 | $4,698,450,000 | 1 / 2 |
| 2026-10-20 | $1.90 | $4,698,450,000 | 1 / 2 |
| 2026-10-21 | $1.90 | $4,698,450,000 | 1 / 2 |
| 2026-10-22 | $1.90 | $4,698,450,000 | 1 / 2 |
| 2026-10-23 | $1.90 | $4,698,450,000 | 1 / 2 |
| 2026-10-24 | $1.90 | $4,698,450,000 | 1 / 2 |
| 2026-10-25 | $1.90 | $4,698,450,000 | 1 / 2 |
| 2026-10-26 | $1.90 | $4,698,450,000 | 1 / 2 |
| 2026-10-27 | $1.90 | $4,698,450,000 | 1 / 2 |
| 2026-10-28 | $1.90 | $4,698,450,000 | 1 / 2 |
| 2026-10-29 | $1.90 | $4,698,450,000 | 1 / 2 |
| 2026-10-30 | $1.90 | $4,698,450,000 | 1 / 2 |
| 2026-10-31 | $1.90 | $4,698,450,000 | 1 / 2 |
| 2026-11-01 | $1.90 | $4,698,450,000 | 1 / 2 |
| 2026-11-02 | $1.90 | $4,698,450,000 | 1 / 2 |
| 2026-11-03 | $1.90 | $4,698,450,000 | 1 / 2 |
| 2026-11-04 | $1.90 | $4,698,450,000 | 1 / 2 |
| 2026-11-05 | $1.90 | $4,698,450,000 | 1 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 5 Buy / Strong Buy · 3 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 2 recorded
0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.